Linoleoyl glycine

CAS No. 2764-03-6

Linoleoyl glycine( —— )

Catalog No. M36086 CAS No. 2764-03-6

Linoleoyl glycine, a modified polyunsaturated fatty acid, is an endogenous homologue of linoleoyl glycine. Linoleoyl glycine activates human KCNQ1/KCNE1 (hKCNQ1/hKCNE1) channels expressed in xenopus oocytes from mammalian skin.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 In Stock
5MG 409 In Stock
10MG 604 In Stock
25MG 908 In Stock
50MG 1251 In Stock
100MG 1647 In Stock
200MG Get Quote In Stock
500MG 3312 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Linoleoyl glycine
  • Note
    Research use only, not for human use.
  • Brief Description
    Linoleoyl glycine, a modified polyunsaturated fatty acid, is an endogenous homologue of linoleoyl glycine. Linoleoyl glycine activates human KCNQ1/KCNE1 (hKCNQ1/hKCNE1) channels expressed in xenopus oocytes from mammalian skin.
  • Description
    Linoleoyl glycine is a modified polyunsaturated fatty acid. Linoleoyl glycine has activating effects on human KCNQ1/KCNE1 (hKCNQ1/hKCNE1) channels expressed in Xenopus oocytes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Potassium Channel
  • Recptor
    Potassium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2764-03-6
  • Formula Weight
    337.5
  • Molecular Formula
    C20H35NO3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (370.37 mM; Ultrasonic )
  • SMILES
    C(CC(NCC(O)=O)=O)CCCCC/C=C\C/C=C\CCCCC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Skarsfeldt MA, et al. Polyunsaturated fatty acid-derived IKs channel activators shorten the QT interval ex-vivo and in-vivo. Acta Physiol (Oxf). 2020;229(4):e13471. ?
molnova catalog
related products
  • VU0810464

    VU0810464 is a non-ureaG protein-gated inwardly-rectifying potassium channels (GIRK Kir3) activator.

  • GAL-021

    A novel respiratory stimulant that acts as a potent calcium-activated potassium (BKCa) channel blocker blocker.

  • BMS-191095

    BMS-191095 is mitochondrial ATP-sensitive potassium (mitoKATP) channel activator.